Insider selling at these levels is immaterial. Monitor for any larger insider transactions or changes in the company's financial outlook, but this cluster alone does not warrant a trading response.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 16 $32.91entry
- T+1 · 5mo ago −1.06%α +0.19% · $32.56
- T+5 · 5mo ago +0.91%α +3.14% · $33.21
- T+20 · 4mo ago −3.31%α −3.51% · $31.82
- T+60 · 2mo ago +10.45%α +9.45% · $36.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two top executives at Teva (CEO and CFO) sold a combined $3.84M in shares over a one-week window, but the total represents only ~0.01% of the company's $39.2B market cap. The dollar amounts are trivial relative to company size, making this a routine liquidity-driven event with no material signal.
Key Financial Metrics
Key Facts
- CEO Richard D. Francis sold 6,200 shares for ~$211K on June 5, 2026.
- CFO Eliyahu Sharon Kalif sold 106,563 shares for ~$3.63M on June 11, 2026.
- Total insider sales of $3.84M represent ~0.01% of Teva's $39.2B market cap.
- Both sales were open-market transactions; no 10b5-1 plan indicated in the filing.
Financial Impact
Total insider sales of $3.84M, negligible relative to $39.2B market cap.
Risk Factors
- Insider sales could increase if management perceives headwinds, but current data shows no pattern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-TEVA-1781612976649 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers